PharmacyCodes



3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium en es it fr

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium Brand names, 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium Analogs

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium Brand Names Mixture

  • No information avaliable

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium Chemical_Formula

C16H16ClN3O4

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium RX_link

http://www.rxlist.com/cgi/generic/loracarb.htm

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium fda sheet

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium msds (material safety sheet)

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium MSDS

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium Synthesis Reference

No information avaliable

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium Molecular Weight

349.769 g/mol

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium Melting Point

No information avaliable

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium H2O Solubility

No information avaliable

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium State

Solid

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium LogP

0.286

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium Dosage Forms

No information avaliable

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium Indication

Used to treat upper respiratory tract bacterial infections, chronic bronchitis, pneumonia, sinusitis, pharyntitis and tonsillitis, skin absceses, urinary tract infections and pyelonephritis caused by E. coli, S. pyogenes, S. aureus, S. saprphyticus, S. penumoniae, H. influenzae and M. catarrhalis.

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium Pharmacology

Loracarbef is considered a second generation cephalosporin antibiotic. The advantages of cephalosporin antibiotics include a broad range of activity, a safe record in children with almost no dose-related toxicity, and the lack of need to monitor levels. Adverse reactions are rare and consist primarily of hypersensitivity reactions with urticaria, nonspecific rash, and pruritus. Loracarbef can be used to treat a large number of bacterial infections caused by gram-negative and gram-positive bacteria, including upper respiratory tract bacterial infections, chronic bronchitis, pneumonia, sinusitis, pharyntitis and tonsillitis, skin absceses, urinary tract infections and pyelonephritis caused by E. coli, S. pyogenes, S. aureus, S. saprphyticus, S. penumoniae, H. influenzae and M. catarrhalis.

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium Absorption

Well absorbed with approximately 90% absorbed from the gastrointestinal tract after oral ingestion.

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium side effects and Toxicity

Adverse effects include diarrhea, nausea, stomach upset, vomiting, headache, dizziness, rash, bone marrow depression.

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium Patient Information

http://www.drugs.com/MTM/lomefloxacin.html

3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium Organisms Affected

Many kinds of gram-negative and gram-positive eubacteria